Circulating Tumor DNA as a Predictive Biomarker for Clinical Outcomes With Margetuximab and Pembrolizumab in Pretreated HER2-Positive Gastric/ Gastroesophageal Adenocarcinoma
10.46883/2023.25920992
Saved in:
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Other Authors: | |
Format: | Article |
Published: |
MJH Life Sciences
2023
|
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/239260 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
id |
sg-nus-scholar.10635-239260 |
---|---|
record_format |
dspace |
spelling |
sg-nus-scholar.10635-2392602024-04-17T09:34:34Z Circulating Tumor DNA as a Predictive Biomarker for Clinical Outcomes With Margetuximab and Pembrolizumab in Pretreated HER2-Positive Gastric/ Gastroesophageal Adenocarcinoma Daniel V. T. Catenacci Yoon-Koo Kang Hope E. Uronis Keun-Wook Lee Matthew C. H. Ng Peter C. Enzinger Se Hoon Park Philip J. Gold Jill Lacy Howard S. Hochster Sang Cheul Oh Yeul Hong Kim Kristen A. Marrone Ronan J. Kelly Rosalyn A. Juergens Jong Gwang Kim Thierry Alcindor Sun Jin Sym Eun-Kee Song Cheng Ean Chee Yee Chao Sunnie Kim Do-Youn Oh Jennifer Yen Justin I. Odegaard Errin Lagow Daner Li Jichao Sun Patrick Kaminker Paul A. Moore Minori Koshiji Rosales Haeseong Park MEDICINE DUKE-NUS MEDICAL SCHOOL 10.46883/2023.25920992 ONCOLOGY 3704 176-183 2023-05-10T00:01:44Z 2023-05-10T00:01:44Z 2023-04-12 2023-05-09T08:07:01Z Article Daniel V. T. Catenacci, Yoon-Koo Kang, Hope E. Uronis, Keun-Wook Lee, Matthew C. H. Ng, Peter C. Enzinger, Se Hoon Park, Philip J. Gold, Jill Lacy, Howard S. Hochster, Sang Cheul Oh, Yeul Hong Kim, Kristen A. Marrone, Ronan J. Kelly, Rosalyn A. Juergens, Jong Gwang Kim, Thierry Alcindor, Sun Jin Sym, Eun-Kee Song, Cheng Ean Chee, Yee Chao, Sunnie Kim, Do-Youn Oh, Jennifer Yen, Justin I. Odegaard, Errin Lagow, Daner Li, Jichao Sun, Patrick Kaminker, Paul A. Moore, Minori Koshiji Rosales, Haeseong Park (2023-04-12). Circulating Tumor DNA as a Predictive Biomarker for Clinical Outcomes With Margetuximab and Pembrolizumab in Pretreated HER2-Positive Gastric/ Gastroesophageal Adenocarcinoma. ONCOLOGY (3704) : 176-183. ScholarBank@NUS Repository. https://doi.org/10.46883/2023.25920992 0890-9091 https://scholarbank.nus.edu.sg/handle/10635/239260 MJH Life Sciences Elements |
institution |
National University of Singapore |
building |
NUS Library |
continent |
Asia |
country |
Singapore Singapore |
content_provider |
NUS Library |
collection |
ScholarBank@NUS |
description |
10.46883/2023.25920992 |
author2 |
MEDICINE |
author_facet |
MEDICINE Daniel V. T. Catenacci Yoon-Koo Kang Hope E. Uronis Keun-Wook Lee Matthew C. H. Ng Peter C. Enzinger Se Hoon Park Philip J. Gold Jill Lacy Howard S. Hochster Sang Cheul Oh Yeul Hong Kim Kristen A. Marrone Ronan J. Kelly Rosalyn A. Juergens Jong Gwang Kim Thierry Alcindor Sun Jin Sym Eun-Kee Song Cheng Ean Chee Yee Chao Sunnie Kim Do-Youn Oh Jennifer Yen Justin I. Odegaard Errin Lagow Daner Li Jichao Sun Patrick Kaminker Paul A. Moore Minori Koshiji Rosales Haeseong Park |
format |
Article |
author |
Daniel V. T. Catenacci Yoon-Koo Kang Hope E. Uronis Keun-Wook Lee Matthew C. H. Ng Peter C. Enzinger Se Hoon Park Philip J. Gold Jill Lacy Howard S. Hochster Sang Cheul Oh Yeul Hong Kim Kristen A. Marrone Ronan J. Kelly Rosalyn A. Juergens Jong Gwang Kim Thierry Alcindor Sun Jin Sym Eun-Kee Song Cheng Ean Chee Yee Chao Sunnie Kim Do-Youn Oh Jennifer Yen Justin I. Odegaard Errin Lagow Daner Li Jichao Sun Patrick Kaminker Paul A. Moore Minori Koshiji Rosales Haeseong Park |
spellingShingle |
Daniel V. T. Catenacci Yoon-Koo Kang Hope E. Uronis Keun-Wook Lee Matthew C. H. Ng Peter C. Enzinger Se Hoon Park Philip J. Gold Jill Lacy Howard S. Hochster Sang Cheul Oh Yeul Hong Kim Kristen A. Marrone Ronan J. Kelly Rosalyn A. Juergens Jong Gwang Kim Thierry Alcindor Sun Jin Sym Eun-Kee Song Cheng Ean Chee Yee Chao Sunnie Kim Do-Youn Oh Jennifer Yen Justin I. Odegaard Errin Lagow Daner Li Jichao Sun Patrick Kaminker Paul A. Moore Minori Koshiji Rosales Haeseong Park Circulating Tumor DNA as a Predictive Biomarker for Clinical Outcomes With Margetuximab and Pembrolizumab in Pretreated HER2-Positive Gastric/ Gastroesophageal Adenocarcinoma |
author_sort |
Daniel V. T. Catenacci |
title |
Circulating Tumor DNA as a Predictive Biomarker for Clinical Outcomes With Margetuximab and Pembrolizumab in Pretreated HER2-Positive Gastric/ Gastroesophageal Adenocarcinoma |
title_short |
Circulating Tumor DNA as a Predictive Biomarker for Clinical Outcomes With Margetuximab and Pembrolizumab in Pretreated HER2-Positive Gastric/ Gastroesophageal Adenocarcinoma |
title_full |
Circulating Tumor DNA as a Predictive Biomarker for Clinical Outcomes With Margetuximab and Pembrolizumab in Pretreated HER2-Positive Gastric/ Gastroesophageal Adenocarcinoma |
title_fullStr |
Circulating Tumor DNA as a Predictive Biomarker for Clinical Outcomes With Margetuximab and Pembrolizumab in Pretreated HER2-Positive Gastric/ Gastroesophageal Adenocarcinoma |
title_full_unstemmed |
Circulating Tumor DNA as a Predictive Biomarker for Clinical Outcomes With Margetuximab and Pembrolizumab in Pretreated HER2-Positive Gastric/ Gastroesophageal Adenocarcinoma |
title_sort |
circulating tumor dna as a predictive biomarker for clinical outcomes with margetuximab and pembrolizumab in pretreated her2-positive gastric/ gastroesophageal adenocarcinoma |
publisher |
MJH Life Sciences |
publishDate |
2023 |
url |
https://scholarbank.nus.edu.sg/handle/10635/239260 |
_version_ |
1800915832881020928 |